Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.36 |
---|---|
High | 2.63 |
Low | 2.24 |
Bid | 0.936 |
Offer | 2.38 |
Previous close | 2.30 |
Average volume | 7.74k |
---|---|
Shares outstanding | 35.62m |
Free float | 33.16m |
P/E (TTM) | -- |
Market cap | 113.89m CAD |
EPS (TTM) | -1.37 CAD |
Data delayed at least 15 minutes, as of Oct 09 2024 20:55 BST.
More ▼
Press releases
- Eupraxia Pharmaceuticals Strengthens Senior Management Team
- Eupraxia Pharmaceuticals to Present at 20th ISDE World Congress for Esophageal Diseases
- Eupraxia Pharmaceuticals Announces Data from RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis
- Eupraxia Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
- Eupraxia Pharmaceuticals Reports Second Quarter 2024 Financial Results
- Eupraxia Pharmaceuticals Announces New C$12 Million Convertible Debt Facility
More ▼